Altering Chemical Structure of Aptamers to Create New Opportunities for Manufacturers
The global aptamers market is oligopolistic in nature, with a few key players, states a new report by Transparency Market Research (TMR). The top three players accounted for 57.8% of the market in 2012. Leading layers in the market have increased their R&D efforts in order to develop novel aptamers for therapeutics and diagnostics. For instance, companies such as NOXXON Pharma AG and Ophthotech Corporation are engaged in the development of novel aptamer products, which are in pipeline. The commercial...
View full press release